Publication | Closed Access

Gefitinib as neoadjuvant therapy for resectable stage II-IIIA non–small cell lung cancer: A phase II study

Surgical OncologyNeoadjuvant TherapyMedicinePathologyPhase Ii StudyBronchial NeoplasmCancer TreatmentOncologyRadiation OncologyLung CancerMolecular Oncology